Professor Beatriz Silva Lima, PharmD, PhD, Non-Clinical Expert for NDA’s Regulatory Advisory Board, is contributing towards a workshop on ATMPs at 2013 PDA Europe Conference on Advanced Therapy Medicinal Products.
Beatriz will specifically talk about ‘iPS cells, can they replace (some) preclinical studies?’ as part of a broader session on Pre-Clinical Studies.
The PDA Advanced Therapy Medicinal Products Conference provides an opportunity to exchange information and thoughts between the industry and regulators of different areas with the aim to improve the understanding of ATMP development and the regulatory expectations in this new and emerging field of medicinal products.
The event takes place in Florence, Italy, on 25-26 June 2013. For further information, please see: https://europe.pda.org/index.php?n1=665&n2=689&id=911&content=Overview